Ingram Micro Holding is set to replace Pacira BioSciences in the S&P SmallCap 600, following a corporate deal in which Viatris acquires Pacira. PR Newswire reports that Ingram Micro will take Pacira’s place effective prior to the opening of trading on Tuesday, November 17.

The change is tied to Viatris’ purchase of Pacira, which affects Pacira’s status as an index constituent. Seeking Alpha frames the development as Ingram Micro joining the SmallCap 600 after the Viatris–Pacira deal, aligning with the index-replacement outcome described by PR Newswire.

Across the two sources, the core point is the same: an index membership switch is scheduled for Ingram Micro in the S&P SmallCap 600, with Pacira leaving, and the underlying reason is the acquisition involving Viatris.